Syngenta shareholders approve $44bn ChemChina merger

With nearly 81 percent of Syngenta shares tendered and all regulatory approvals secured, the $44 billion dollar deal is on track to close in June.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.